Professor Kausik Ray - PCSK9 inhibition – have we reached the limits of lipid lowering and outcome?
26:14
Professor Steven Nissen - Lipoprotein(a): a new target for therapeutic intervention
52:04
A Real World Approach to LDL cholesterol using PCSK9 inhibitors, October 5 2018
58:08
The Cholesterol Wars: Identifying Patients Who Would Most Benefit from PCSK9 Inhibitors (Part 1)
25:34
Professor Peter Libby
12:51
Vulgar Replies To Musk's Email | Trump's Mystery Bruise | Hooters In Trouble
17:08
Lipids Series-PCS K9 Inhibitors
24:30
Professor Richard Schilling
10:40